Barclays
VERA icon

Barclays’s Vera Therapeutics VERA Stock Holding History

Barclays’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.8M Buy
272,597
+47,479
+21% +$1.66M ﹤0.01% 1718
2026
Q2 		$9.7M Sell
225,118
-7,398
-3% -$276K ﹤0.01% 1495
2026
Q1 		$9.35M Sell
232,516
-21,200
-8% -$913K ﹤0.01% 1486
2025
Q4 		$12.8M Buy
253,716
+36,123
+17% +$1.28M ﹤0.01% 1505
2025
Q3 		$6.32M Buy
217,593
+6,716
+3% +$155K ﹤0.01% 2014
2025
Q2 		$4.97M Buy
210,877
+121,161
+135% +$2.72M ﹤0.01% 2143
2025
Q1 		$2.15M Sell
89,716
-9,432
-10% -$303K ﹤0.01% 2574
2024
Q4 		$4.19M Buy
99,148
+13,753
+16% +$609K ﹤0.01% 2320
2024
Q3 		$3.77M Buy
85,395
+41,394
+94% +$1.57M ﹤0.01% 2320
2024
Q2 		$1.59M Buy
44,001
+433
+1% +$17.2K ﹤0.01% 2298
2024
Q1 		$1.88M Sell
43,568
-70,179
-62% -$2.5M ﹤0.01% 2622
2023
Q4 		$1.75M Buy
113,747
+42,044
+59% +$534K ﹤0.01% 3026
2023
Q3 		$983K Buy
71,703
+64,968
+965% +$1.11M ﹤0.01% 2351
2023
Q2 		$108K Sell
6,735
-4,237
-39% -$38.3K ﹤0.01% 3524
2023
Q1 		$85.1K Sell
10,972
-2,307
-17% -$17.8K ﹤0.01% 4266
2022
Q4 		$257K Buy
13,279
+3,254
+32% +$58.9K ﹤0.01% 3709
2022
Q3 		$214K Buy
10,025
+9,329
+1,340% +$175K ﹤0.01% 3158
2022
Q2 		$9K Sell
696
-1,526
-69% -$26.6K ﹤0.01% 4669
2022
Q1 		$53K Buy
+2,222
New +$47.8K ﹤0.01% 4101

Other funds holding VERA

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.2B AUM 25.19% 1-Year Est. Return

Barclays's VERA Position: Q3 2026 in Review

Barclays increased its Vera Therapeutics (VERA) stake by 21% in Q3 2026, buying an estimated $1.66M and bringing the position to 272,597 shares worth $8.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1718.

Barclays first reported a position in VERA in Q1 2022 and has held it in 19 quarters since. The position peaked at $12.8M in Q4 2025. 67 funds tracked by Wall St. Rank hold VERA as of Q3 2026.

  • Barclays held 272,597 shares of Vera Therapeutics worth $8.8M as of Q3 2026.
  • Barclays bought 47,479 Vera Therapeutics shares in Q3 2026, an estimated $1.66M.
  • Vera Therapeutics made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #1718 holding.
  • Barclays first reported a position in Vera Therapeutics in Q1 2022 and has held it in 19 quarters since.
  • Barclays's Vera Therapeutics position peaked at $12.8M in Q4 2025.
  • 67 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.